Tocilizumab in Cardiac Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jon A. Kobashigawa, MD
Cedars Sinai Medical Center: Transplantation
Study Chair - Joren C. Madsen, MD, DPHIL
Massachusetts General Hospital: Transplantation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars Sinai Medical Center (cacs)
Beverly Hills, California, United States
- University of California, San Diego: Sulpizio Cardiovascular Center (casd)
La Jolla, California, United States
- Stanford Health Care (casu)
Stanford, California, United States
- Tampa General Hospital (fltg)
Tampa, Florida, United States
- Northwestern Memorial Hospital (inlm)
Chicago, Illinois, United States
- Massachusetts General Hospital (mamg)
Boston, Massachusetts, United States
- Tufts Medical Center (manm)
Boston, Massachusetts, United States
- St. Luke'S Hospital of Kansas City (molh)
Kansas City, Missouri, United States
- University of Nebraska Medical Center (neun)
Omaha, Nebraska, United States
- Columbia University Medical Center (nycp)
New York, New York, United States
- Mount Sinai Medical Center (nyms)
New York, New York, United States
- Montefiore Medical Center (nyma)
The Bronx, New York, United States
- Duke University Medical Center (ncdu)
Durham, North Carolina, United States
- Cleveland Clinic Foundation (ohcc)
Cleveland, Ohio, United States
- Penn State Health: Milton S. Hershey Medical Center (pahe)
Hershey, Pennsylvania, United States
- Hospital of the University of Pennsylvania (paup)
Philadelphia, Pennsylvania, United States
- Allegheny General Hospital (paag)
Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center (tnvu)
Nashville, Tennessee, United States
- Baylor University Medical Center (txtx)
Dallas, Texas, United States
- University of Utah (utmc)
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2018
- Primary completion
- 25 Mar 2025
- Completion
- 25 Mar 2025
- Last update posted
- 7 Apr 2026
- Registered enrollment
- 385
- Registry id
- NCT03644667
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.